机译:BZLF1-DEC205融合蛋白在EBV驱动淋巴抑制性疾病的自发模型中提高EBV-Protective免疫力
Ohio State Univ Coll Vet Med Dept Vet Biosci Columbus OH 43210 USA;
Ohio State Univ James Canc Hosp Comprehens Canc Ctr Columbus OH 43210 USA;
Ohio State Univ James Canc Hosp Comprehens Canc Ctr Columbus OH 43210 USA;
Ohio State Univ James Canc Hosp Comprehens Canc Ctr Columbus OH 43210 USA;
Ohio State Univ James Canc Hosp Comprehens Canc Ctr Columbus OH 43210 USA;
Ohio State Univ James Canc Hosp Comprehens Canc Ctr Columbus OH 43210 USA;
Ohio State Univ Dept Internal Med Div Hematol Columbus OH 43210 USA;
Ohio State Univ Educ &
Human Ecol Columbus OH 43210 USA;
Ohio State Univ Dept Biomed Engn Columbus OH 43210 USA;
Ohio State Univ James Canc Hosp Comprehens Canc Ctr Columbus OH 43210 USA;
Ohio State Univ James Canc Hosp Comprehens Canc Ctr Columbus OH 43210 USA;
Ohio State Univ James Canc Hosp Comprehens Canc Ctr Columbus OH 43210 USA;
Ohio State Univ James Canc Hosp Comprehens Canc Ctr Columbus OH 43210 USA;
机译:BZLF1-DEC205融合蛋白在EBV驱动淋巴抑制性疾病的自发模型中提高EBV-Protective免疫力
机译:CD19靶向融合蛋白与PD1抗体相结合,可增强小鼠模型中的抗肿瘤免疫力
机译:使用由外膜蛋白(29 kDa)和PilE融合蛋白组成的DNA疫苗在A / J小鼠模型中对退伍军人症的保护性免疫
机译:肽病毒融合抑制剂的快速发现迫切治疗和预防病毒Ⅰ型病毒融合蛋白引起的新出现传染病
机译:识别和靶向爱泼斯坦-巴尔病毒驱动的淋巴增生性疾病的免疫逃逸机制
机译:BZLF1至DEC205的有针对性的递送在EBV驱动的淋巴抑制性疾病的自发模型中推动EBV-Protective免疫力
机译:印度人恒河猴猕猴模型中内源性逆转录病毒K包膜蛋白的鉴定和自发免疫靶向